Robert Kridel

7.0k total citations
81 papers, 2.0k citations indexed

About

Robert Kridel is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Robert Kridel has authored 81 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pathology and Forensic Medicine, 34 papers in Oncology and 23 papers in Genetics. Recurrent topics in Robert Kridel's work include Lymphoma Diagnosis and Treatment (56 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Viral-associated cancers and disorders (16 papers). Robert Kridel is often cited by papers focused on Lymphoma Diagnosis and Treatment (56 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Viral-associated cancers and disorders (16 papers). Robert Kridel collaborates with scholars based in Canada, United States and Switzerland. Robert Kridel's co-authors include Randy D. Gascoyne, Laurie H. Sehn, Joseph M. Connors, Christian Steidl, King Tan, David W. Scott, Susana Ben‐Neriah, Pierre‐Yves Dietrich, Graham W. Slack and Kerry J. Savage and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Robert Kridel

66 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Kridel Canada 21 1.4k 1.0k 593 482 412 81 2.0k
Irina Bonzheim Germany 26 1.1k 0.8× 948 0.9× 535 0.9× 376 0.8× 427 1.0× 87 1.9k
Itziar Salaverría Spain 33 1.8k 1.3× 1.2k 1.2× 849 1.4× 657 1.4× 259 0.6× 58 2.5k
King Tan Canada 15 1.1k 0.8× 812 0.8× 427 0.7× 259 0.5× 333 0.8× 31 1.5k
Maria Calaminici United Kingdom 19 1.3k 1.0× 985 1.0× 547 0.9× 227 0.5× 639 1.6× 44 1.8k
Jörg Kalla Germany 25 1.6k 1.2× 1.0k 1.0× 723 1.2× 341 0.7× 269 0.7× 40 2.0k
Eugenia Haralambieva Germany 24 1.3k 0.9× 883 0.9× 533 0.9× 637 1.3× 370 0.9× 52 2.1k
Evelyne Callet‐Bauchu France 26 1.8k 1.3× 906 0.9× 1.1k 1.9× 542 1.1× 406 1.0× 62 2.6k
András Matolcsy Hungary 24 988 0.7× 583 0.6× 699 1.2× 495 1.0× 381 0.9× 106 1.9k
Susana Ben‐Neriah Canada 22 1.9k 1.4× 1.3k 1.3× 990 1.7× 504 1.0× 430 1.0× 60 2.6k
Daisuke Ennishi Japan 20 958 0.7× 656 0.6× 452 0.8× 289 0.6× 253 0.6× 109 1.5k

Countries citing papers authored by Robert Kridel

Since Specialization
Citations

This map shows the geographic impact of Robert Kridel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Kridel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Kridel more than expected).

Fields of papers citing papers by Robert Kridel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Kridel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Kridel. The network helps show where Robert Kridel may publish in the future.

Co-authorship network of co-authors of Robert Kridel

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Kridel. A scholar is included among the top collaborators of Robert Kridel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Kridel. Robert Kridel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aoki, Tomohiro, Mary Salib, Michael Hong, et al.. (2025). Distinct characteristics and social determinants in adult T‐cell leukaemia/lymphoma patients at a tertiary cancer centre in Canada. British Journal of Haematology. 207(1). 132–140.
2.
Mirshahvalad, Seyed Ali, Andrés Kohan, Claudia Ortega, et al.. (2025). Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy. Scientific Reports. 15(1). 39540–39540.
3.
Wright, George W., Hongli Li, James R. Cerhan, et al.. (2025). Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma. Blood Advances. 9(24). 6443–6454.
4.
AminiLari, Mahmood, Xiang Y. Ye, Ur Metser, et al.. (2025). Outcomes of Primary Mediastinal B-cell Lymphoma Patients with Partial Metabolic Response: A Multicenter Retrospective Analysis. Advances in Radiation Oncology. 10(5). 101744–101744.
5.
Mirshahvalad, Seyed Ali, Andrés Kohan, Claudia Ortega, et al.. (2025). Prognostic value of early post-treatment 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy. Cancer Imaging. 25(1). 70–70. 1 indexed citations
6.
Strati, Paolo, Richy Agajanian, Izidore S. Lossos, et al.. (2024). Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open‐label study ( ACELY ‐003). British Journal of Haematology. 206(3). 887–898. 2 indexed citations
7.
Sabatini, Peter, Joshua Bridgers, Shujun Huang, et al.. (2024). Multisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognostication. Journal of Clinical Pathology. 78(3). 187–194. 2 indexed citations
8.
Xiao, Yufeng, Nikee Awasthee, Yi Liu, et al.. (2024). Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8. Journal of Medicinal Chemistry. 67(15). 12784–12806. 8 indexed citations
9.
Bridgers, Joshua, Shujun Huang, Barbara Meissner, et al.. (2024). Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing. Clinical Chemistry. 70(1). 273–284. 2 indexed citations
10.
Bhella, Sita, Robert Kridel, Vishal Kukreti, et al.. (2022). Clinical utility of interim CT scans in patients receiving chemoimmuntherapy for first line treatment of follicular lymphoma. Leukemia & lymphoma. 63(14). 3402–3408.
11.
Tong, Kit I., Keren Isaev, Gilbert G. Privé, et al.. (2021). Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma. Clinical Cancer Research. 27(19). 5401–5414. 16 indexed citations
12.
Hung, Stacy, Barbara Meissner, Elizabeth A. Chavez, et al.. (2018). Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management. Journal of Molecular Diagnostics. 20(2). 203–214. 53 indexed citations
13.
Oricchio, Elisa, Natalya Katanayeva, Maria Donaldson Collier, et al.. (2017). Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma. Science Translational Medicine. 9(396). 49 indexed citations
14.
Goswami, Rashmi S., et al.. (2017). Pathogenesis of follicular lymphoma. Best Practice & Research Clinical Haematology. 31(1). 2–14. 34 indexed citations
15.
Gravelle, Pauline, Catherine Do, Camille Franchet, et al.. (2016). Impaired functional responses in follicular lymphoma CD8+TIM-3+T lymphocytes following TCR engagement. OncoImmunology. 5(10). e1224044–e1224044. 31 indexed citations
16.
Kridel, Robert, Laurie H. Sehn, & Randy D. Gascoyne. (2012). Pathogenesis of follicular lymphoma. Journal of Clinical Investigation. 122(10). 3424–3431. 196 indexed citations
17.
Kridel, Robert & Jean‐Claude Pache. (2009). Pulmonary Tumor Embolism. Journal of Thoracic Oncology. 4(6). 777–778. 1 indexed citations
18.
Kridel, Robert, Christian van Delden, Thierry Calandra, & Oscar Marchetti. (2008). Antibiothérapie empirique lors de neutropénie fébrile [Empirical antibiotic therapy for febrile neutropenia]. SERVAL (Université de Lausanne). 3 indexed citations
19.
Kridel, Robert, Christian van Delden, Thierry Calandra, & Oscar Marchetti. (2008). Antibiothérapie empirique lors de neutropénie fébrile. Archive ouverte UNIGE (University of Geneva). 2 indexed citations
20.
Kridel, Robert, et al.. (2008). [Empirical antibiotic therapy for febrile neutropenia].. PubMed. 4(152). 914, 916–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026